A clinical study to test efficacy of Withania Somnifera in patients with chronic pelvic pain

A RANDOMISED SINGLE BLIND PLACEBO CONTROLLED CLINICAL STUDY TO TEST THE EFFICACY OF WITHANIA SOMNIFERA (L) (ASGANDH ) IN PATIENTS WITH WAJA UL AANA MUZMIN( CHRONIC PELVIC PAIN ) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/01/079268

Enrollment

Registered

2025-01-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R102- Pelvic and perineal pain

Interventions

Intervention1: Sufoof e asgandh and zimad e asgandh: Group A will be given Sufoof E Asgandh 2 gms morning and evening for 40 days orally Zimad e Asgandh 10 gms morning and evening for local applicat

Eligibility

Inclusion criteria

Inclusion criteria: 1. Woman of age 21 To 50 Years. 2. Chronic Pelvic Inflammatory Disease. 3. Pelvic Venous Congestion. 4. Adhesions. 5. Residual Ovary Syndrome. 6. Chronic Cervicitis. 7. IUCD. 8. Fibromyalgia. 9. Trigger Points. 10. Damaged Nerves. 11. Pudendal Neuralgia. 12. Abdominal Wall Myofascial Pain. 13. Depression or Anxiety Or Sleep Disorders.

Exclusion criteria

Exclusion criteria: 1. Pregnant Women. 2. Woman with Comorbidities. 3. Bleeding Disorders. 4. Adenomyosis. 5. Endometriosis. 6. GI and Urinary disorders.

Design outcomes

Primary

Measure	Time frame
Pain reliefTimepoint: 0th day , 41st day	—

Secondary

Measure	Time frame
Improvement in quality of lifeTimepoint: 0th day , 41st day	—

Countries

India

Contacts

Public ContactDr Sadiya begum

Government Nizamia Tibbi College and general hospital Charminar Hyderabad Telangana 500002

syedaabidunnisa@gmail.com949202708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026